KROS

15.55

1.33% -0.21

Dopo l'orario di chiusura: 15.55

Keros Therapeutics Inc (KROS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché KROS Giù? Forum Previsione

Precedente Chiudi:

$15.76

Aprire:

$15.73

Volume 24 ore:

201.84K

Relative Volume:

0.40

Capitalizzazione di mercato:

$631.57M

Reddito:

Utile/perdita netta:

$-168.05M

Rapporto P/E:

-3.0312

EPS:

-5.13

Flusso di cassa netto:

$-146.15M

1 W Prestazione:

+1.97%

1M Prestazione:

+6.36%

6M Prestazione:

+34.17%

1 anno Prestazione:

-70.62%

Intervallo 1D:

$15.38

$15.73

Intervallo di 1 settimana:

$14.97

$16.07

Portata 52W:

$9.12

$72.37

Keros Therapeutics Inc Stock (KROS) Company Profile

Nome

Keros Therapeutics Inc

Settore

Healthcare (1151)

Industria

Biotechnology (646)

Telefono

617-314-6297

Indirizzo

1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA

Dipendente

148

Cinguettio

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

KROS's Discussions on Twitter

Confronta KROS con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
KROS Keros Therapeutics Inc	15.55	638.47M	0	-168.05M	-146.15M	-5.13
VRTX Vertex Pharmaceuticals Inc	396.93	102.81B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	453.54	58.59B	2.46B	-319.09M	-52.09M	-2.47
REGN Regeneron Pharmaceuticals Inc	567.22	61.25B	14.21B	4.46B	3.56B	39.68
ARGX Argen X Se Adr	733.66	43.23B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	318.73	36.53B	3.81B	-644.79M	-669.77M	-6.24

Keros Therapeutics Inc Stock (KROS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-06-10	Downgrade	BofA Securities	Buy → Neutral
2025-01-21	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2025-01-17	Downgrade	Wedbush	Outperform → Neutral
2024-12-16	Downgrade	Guggenheim	Buy → Neutral
2024-12-16	Reiterato	Oppenheimer	Outperform
2024-12-13	Reiterato	H.C. Wainwright	Buy
2024-12-12	Downgrade	BTIG Research	Buy → Neutral
2024-12-12	Downgrade	TD Cowen	Buy → Hold
2024-12-12	Downgrade	William Blair	Outperform → Mkt Perform
2024-11-05	Iniziato	Jefferies	Buy
2024-10-24	Iniziato	Cantor Fitzgerald	Overweight
2024-10-16	Iniziato	Scotiabank	Sector Outperform
2024-09-23	Iniziato	Guggenheim	Buy
2024-06-25	Iniziato	Oppenheimer	Outperform
2024-02-21	Iniziato	William Blair	Outperform
2023-12-08	Iniziato	Wells Fargo	Overweight
2023-07-31	Iniziato	Wedbush	Outperform
2023-07-26	Iniziato	BofA Securities	Buy
2023-02-14	Iniziato	Cowen	Outperform
2022-10-18	Iniziato	Truist	Buy
2022-07-26	Iniziato	BTIG Research	Buy
2020-12-08	Reiterato	H.C. Wainwright	Buy
2020-05-04	Iniziato	H.C. Wainwright	Buy
2020-05-04	Iniziato	Jefferies	Buy
2020-05-04	Iniziato	Piper Sandler	Overweight
2020-05-04	Iniziato	SVB Leerink	Outperform

Mostra tutto

Keros Therapeutics Inc Borsa (KROS) Ultime notizie

Sep 03, 2025

Charles Schwab Investment Management Inc. Reduces Stake in Keros Therapeutics, Inc. $KROS - MarketBeat

Sep 03, 2025

Technical signs of recovery in Keros Therapeutics Inc.Portfolio Update Summary & Safe Capital Growth Tips - Newser

Sep 03, 2025

What candlestick patterns are forming on Keros Therapeutics Inc.Weekly Profit Analysis & Real-Time Chart Pattern Alerts - Newser

Sep 03, 2025

How to escape a deep drawdown in Keros Therapeutics Inc.Analyst Upgrade & Weekly Watchlist of Top Performers - Newser

Sep 03, 2025

Real time alert setup for Keros Therapeutics Inc. performance - Newser

Sep 03, 2025

What MACD and RSI say about Keros Therapeutics Inc.2025 Trading Recap & Weekly Watchlist for Hot Stocks - Newser

Sep 03, 2025

Keros Therapeutics Inc. stock outlook for YEAR2025 Support & Resistance & Safe Entry Trade Signal Reports - Newser

Sep 03, 2025

What institutional flow reveals about Keros Therapeutics Inc.Quarterly Market Review & Smart Allocation Stock Tips - Newser

Sep 03, 2025

Short interest data insights for Keros Therapeutics Inc.Portfolio Profit Report & Weekly Top Performers Watchlists - Newser

Sep 03, 2025

Published on: 2025-09-03 02:58:10 - Newser

Sep 03, 2025

Tick level data insight on Keros Therapeutics Inc. volatilityJuly 2025 Outlook & Daily Momentum Trading Reports - Newser

Sep 03, 2025

Leading vs lagging indicators on Keros Therapeutics Inc. performanceJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser

Sep 03, 2025

Sep 02, 2025

Can Keros Therapeutics Inc. lead its sector in growthMarket Activity Report & Accurate Trade Setup Notifications - khodrobank.com

Sep 02, 2025

Jump Financial LLC Acquires Shares of 103,826 Keros Therapeutics, Inc. $KROS - MarketBeat

Sep 02, 2025

Keros Therapeutics shares rise 1.46% after-hours following the release of DelveInsight's TGFB Inhibitor Pipeline Outlook 2025 report. - AInvest

Sep 02, 2025

Will Keros Therapeutics Inc. stock go up soonJuly 2025 Opening Moves & Expert Verified Stock Movement Alerts - Newser

Sep 02, 2025

Using AI based signals to follow Keros Therapeutics Inc.2025 Market Outlook & Fast Entry and Exit Trade Plans - Newser

Sep 02, 2025

Keros Therapeutics Inc. stock trend forecastPortfolio Return Report & Low Drawdown Trading Strategies - Newser

Sep 02, 2025

What is the target price for Keros Therapeutics Inc. stock2025 Year in Review & Fast Gaining Stock Reports - khodrobank.com

Sep 02, 2025

DRW Securities LLC Invests $4.74 Million in Keros Therapeutics, Inc. $KROS - MarketBeat

Sep 02, 2025

Does Keros Therapeutics Inc. stock have upside surprise potentialWeekly Earnings Recap & Stock Timing and Entry Methods - khodrobank.com

Sep 02, 2025

Intraday pattern recognizer results for Keros Therapeutics Inc.IPO Watch & Safe Capital Growth Trade Ideas - Newser

Sep 02, 2025